[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
D000368:Aged; D000818:Animals; D001570:Benzodiazepinones / Q000378:metabolism*; D001665:Binding Sites; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D005445:Flunitrazepam / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism*; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009457:Neuroglia / Q000032:analysis; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011955:Receptors, Drug / Q000032:analysis; D011963:Receptors, GABA-A
D001570:Benzodiazepinones; D011759:Pyrrolidines; D011955:Receptors, Drug; D011963:Receptors, GABA-A; C028513:4'-chlorodiazepam; D005445:Flunitrazepam; D007608:Kainic Acid